[Clinico-immunologic characteristics of erysipelas in workers at large industrial plants and the therapeutic effect of reaferon].
Peresadin
N A
NA
Pustovoĭ
Iu G
IuG
Gavrilova
L A
LA
D000276:Adjuvants, Immunologic; D000328:Adult; D002617:Chemical Industry; D009783:Dermatitis, Occupational / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D004886:Erysipelas / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D007958:Leukocyte Count / Q000187:drug effects; D008231:Lymphopenia / Q000150:complications* / Q000628:therapy; D008297:Male; D008669:Metallurgy; D008875:Middle Aged; D009894:Opportunistic Infections / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D011994:Recombinant Proteins; D013601:T-Lymphocytes / Q000276:immunology*; D014455:Ukraine
D000276:Adjuvants, Immunologic; D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
Kliniko-immunologicheskie osobennosti rozhi u rabochikh krupnogo promyshlennogo proizvodstva i lechebnyĭ éffekt reaferona.